APA (7th ed.) Citation

JS, L., PE, P., & EF, S. (2010). Osteoblastic bone lesions developing during treatment with erlotinib indicate major response in patients with non-small cell lung cancer: A brief report. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 5(4), 554. https://doi.org/10.1097/JTO.0b013e3181d3e47e

Chicago Style (17th ed.) Citation

JS, Lind, Postmus PE, and Smit EF. "Osteoblastic Bone Lesions Developing During Treatment with Erlotinib Indicate Major Response in Patients with Non-small Cell Lung Cancer: A Brief Report." Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer 5, no. 4 (2010): 554. https://doi.org/10.1097/JTO.0b013e3181d3e47e.

MLA (9th ed.) Citation

JS, Lind, et al. "Osteoblastic Bone Lesions Developing During Treatment with Erlotinib Indicate Major Response in Patients with Non-small Cell Lung Cancer: A Brief Report." Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer, vol. 5, no. 4, 2010, p. 554, https://doi.org/10.1097/JTO.0b013e3181d3e47e.